Recent recalls of eye drops and ointments are due to potential sterility issues identified by the FDA inspection.
The recalls demonstrate that health safety systems are functioning well, according to expert Tim Corson.
Eye drops face higher health risks as they are applied directly to the eye, bypassing natural defenses against contaminants.
Increased regulatory oversight and FDA inspections have led to a spike in recalls, rather than an increase in manufacturing issues, says Dr. Corson.
[
add
]
[
|
|
...
]